What You Should Know:
- The FDA granted Emergency Use Authorization to Eko for an ECG-based algorithm that screens for low ejection fraction, as part of an assessment of cardiac complications and co-morbidities associated with COVID-19.
- This ECG-based deep learning algorithm, developed on a large clinical dataset in collaboration with the Mayo Clinic, can help efficiently identify signs of possible heart failure in patients.
Eko, a digital health
company building
Read More
Cardiac Monitoring
Stanford Alumni Scientists, Physicians Launch StartX Med COVID-19 Task Force
What You Should Know:
- More than 1500 Stanford faculty and alumni announced the launch of StartX Med COVID-19 Task Force featuring 70+ StartX Med Innovators with medical breakthroughs for the prevention, diagnostics, and treatment of coronavirus mobilize efforts to fast-track public health needs during the pandemic.
- The StartX Med COVID-19 Task Force will collaborate on outreach to government agencies, regulatory bodies and healthcare systems in the interest of public health for
Read More
Eko Unveils Redesigned Smart Stethoscope and Stethoscope Attachment
- Eko unveils the second generation of CORE products, which includes a smart stethoscope and a stethoscope attachment designed to make any existing stethoscope smarter.- The technological advancements of the CORE include active noise cancellation, sleeker design, and powerful software to allow medical professionals to more effectively screen for heart disease.- The CORE Digital Attachment ($199) and the fully assembled CORE Digital Stethoscope ($249) are available for pre-order now to healthcare
Read More
Heart Failure is Detectable at Point of Care Using ECG-Enabled Stethoscope, Mayo Clinic and Eko Finds
- Eko and Mayo Clinic announced they have proven that heart failure is detectable during routine physical exams, further validating the Eko DUO digital stethoscopes as a heart failure screening tool. - Today’s news marks the first time that a point of care device with a single lead ECG combined with an AI algorithm identified low ejection fraction in patients.- The results of these findings, which are comparable to research published earlier this year in NatureMedicine, were presented over the
Read More
FDA Clears AI-Powered EchoGo Core for Early Detection of Cardiovascular Disease
- Ultromics has just become one of the first companies to have 510(k) FDA clearance for an AI medical device. - EchoGo will now be available for clinicians in the UK and US to use to help them identify cardiovascular disease earlier. - EchoGo automates cardiac measurements and is the first AI application to measure cardiac strain, improving patient care and outcomes.Ultromics, the UK-based health technology firm at the forefront of applying artificial intelligence to echocardiography has
Read More
Eko Raises $20M to Expand Machine Learning Platform for Cardiac Monitoring/Analysis
- AI-driven digital health startup Eko raises $20M led by ARTIS Ventures with participation from 3M and Mayo Clinic.
- Funding will be used to accelerate research and development (R&D) and commercialization of Eko’s machine learning platform for cardiac screening/analysis.
- Eko’s cardiac monitor combines digital stethoscope and ECG technology both for in-clinic and at-home monitoring, which enables patients to seamlessly and consistently send cardiac data to their
Read More
Machine Learning Algorithm Can Predict Which Cardiac Patients Are High-Risk Post Discharge
- New Mayo Clinic peer-reviewed study shows Medial EarlySign’s machine learning algorithm can predict which cardiac patients are at high-risk following discharge.
- The analysis was based on electronic health records (EHR), demographics, and social data collected from a cohort of 11,709 unique Mayo Clinic patients who underwent 14,349 PCIs during 14,024 hospital admissions.
- The study suggests AI solution can be more effective than traditional models to identify patients at risk of
Read More
Backed by Mayo Clinic Study, Eko Launches Cardiac Remote Monitoring App, Eko Home
Currently being used in a study by Mayo Clinic, cardiac monitoring app Eko Home enhances outpatient cardiac data collection and demonstrates real world efficacyEko, a Silicon Valley-based digital health company applying machine learning in the fight against heart disease, today announced its cardiac remote monitoring app, Eko Home. The app is a first-of-its-kind service that enables precise remote monitoring of cardiac function using ECG and heart sounds. Eko Home can be used to create drug-data
Read More
What’s the Difference: A Look at Consumer and Medical-Grade Wearables in Healthcare
Can both consumer and medical-grade wearables work together to fill healthcare’s care gaps? Dr. Sunil Kapur shares his insights.
What does Abbott’s Confirm Rx insertable cardiac monitor (ICM) and the latest Apple Watch have in common? The answer: more than you think, and perhaps not nearly enough. Today, consumer and medical-grade wearables may live in different markets, but they are aligning on a similar long-term objective—capturing critical data to improve outcomes.
“People want to
Read More
5 Disruptive Technologies Driving The Future of Patient Monitoring Solutions
The patient monitoring market is expected to be worth more than $350 billion by 2025, as the focus is likely to move beyond device
sales to solutions, according to a recent Frost & Sullivan's report.
The report, Patient
Monitoring Industry—Analysis of Investment and Trends outlines the
future of patient monitoring across the continuum of care, the shifts in the
market, and investment opportunities.
Evolution of
Patient Monitoring
Patient monitoring has evolved from
Read More
